Atlas Trials

Entinostat Neuroendocrine (NE) Tumor

Clinical trial NCT03211988 · TERMINATED

Trial details

NCT number
NCT03211988
Sponsor
Antonio Fojo
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2017-12-13
Primary completion
2021-08-24
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.